We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$603M
AUM Growth
-$46M
Cap. Flow
+$9.01M
Cap. Flow %
1.49%
Top 10 Hldgs %
95.51%
Holding
17
New
–
Increased
6
Reduced
6
Closed
–

Top Buys

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$11.8M
2
AMRN
Amarin Corp
AMRN
+$5.85M
3
PGEN icon
Precigen
PGEN
+$4.44M
4
PACB icon
Pacific Biosciences
PACB
+$3.77M
5
NXTM
NxStage Medical Inc.
NXTM
+$1.23M

Top Sells

Rank Stock Value
1
OPK icon
Opko Health
OPK
+$10.5M
2
ARAY icon
Accuray
ARAY
+$5.14M
3
AXDX
Accelerate Diagnostics
AXDX
+$1.43M
4
MZOR
Mazor Robotics Ltd.
MZOR
+$1.05M
5
QDEL icon
QuidelOrtho
QDEL
+$343K

Sector Composition

Rank Sector Weight
1 Healthcare 90.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$168M 27.84%
1,248,086
+93,764
+8% +$11.8M
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$104M 17.32%
503,239
-6,034
-1% -$1.43M
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
$71.3M 11.83%
2,721,636
+49,700
+2% +$1.23M
MZOR
4
DELISTED
Mazor Robotics Ltd.
MZOR
$59.6M 9.89%
2,719,942
-46,575
-2% -$1.05M
QDEL icon
5
QuidelOrtho
QDEL
$1.21B
$53.9M 8.94%
2,517,554
-16,000
-0.6% -$343K
OPK icon
6
Opko Health
OPK
$978M
$32.9M 5.45%
3,534,539
-1,012,281
-22% -$10.5M
AMRN
7
Amarin Corp
AMRN
$297M
$24.4M 4.05%
396,750
+92,036
+30% +$5.85M
PACB icon
8
Pacific Biosciences
PACB
$441M
$21M 3.48%
5,516,894
+518,328
+10% +$3.77M
BIOL
9
DELISTED
Biolase, Inc.
BIOL
$20.5M 3.4%
1,170
+32
+3% +$633K
PGEN icon
10
Precigen
PGEN
$2.36B
$19.9M 3.31%
827,975
+159,369
+24% +$4.44M
VRML
11
DELISTED
Vermillion, Inc.
VRML
$8.19M 1.36%
8,624,225
– –
AGEN
12
Agenus
AGEN
$326M
$7.93M 1.32%
98,126
-3,001
-3% -$295K
ARAY icon
13
Accuray
ARAY
$32.2M
$6.86M 1.14%
1,490,879
-991,839
-40% -$5.14M
CFRX
14
DELISTED
ContraFect Corporation
CFRX
$2.07M 0.34%
1,478
– –
BIIB icon
15
Biogen
BIIB
$29.8B
$1.91M 0.32%
6,723
– –
VANI icon
16
Vivani Medical
VANI
$115M
$100K 0.02%
2,117
– –
TCRT icon
17
Alaunos Therapeutics
TCRT
$4.65M
$36K 0.01%
44
– –

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Oracle Investment Management held 17 positions worth $603M, down 7.1% from $649M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 0%. Oracle Investment Management opened no new positions and made no exits, leaving the 17-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier.

  • Oracle Investment Management added most to TESARO, Inc. in Q4 2016, an estimated $11.8M increase.
  • Oracle Investment Management's biggest Q4 2016 reduction was Opko Health, cutting an estimated $10.5M.
  • Oracle Investment Management's ten largest holdings make up 96% of its $603M portfolio in Q4 2016.
  • Oracle Investment Management opened 0 new positions and closed 0 in Q4 2016.
  • Oracle Investment Management's portfolio value fell 7.1% quarter-over-quarter to $603M.

Based on Oracle Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.